Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Hauber

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Vaccines|April 23, 2025
Do We Have a Common Understanding of How Vaccine Policy Affects Health Equity? Evaluating Variability in the Advisory Committee on Immunization Practices' Equity AssessmentKathleen Dooling, Elif Alyanak, Dial Hewlett, et al.
BMC Infectious Diseases|February 19, 2025
Patient preferences for long-acting HIV treatment: a preference heterogeneity assessmentEnrique M Saldarriaga, Brett Hauber, Douglas Barthold, et al.
Journal of Patient Experience|November 29, 2023
Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug DevelopmentMaggie Jalowsky, Brett Hauber, Mariah Jacqueline Scott, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 15, 2015
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitusA Brett Hauber, Kaan Tunceli, Jui-Chen Yang, et al.
Patient Preference and Adherence|June 26, 2024
Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping ReviewBrett Hauber, Mark V Hand, Bruno C Hancock, et al.
Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Caution is needed for systematic reviews and interpretation of preference studiesJennifer A Whitty, Brett Hauber, Josh Coulter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 26, 2025
A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision MakingJonathan Mauer, Chiara Whichello, Brett Hauber, et al.
Pulmonary Therapy|October 28, 2024
Perspectives on Drug Product Design Among Patients with Lung Cancer in the United KingdomJoshua R Coulter, Louis Edward Baig, Amy Antipas, et al.
The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Vaccines|April 23, 2025
Do We Have a Common Understanding of How Vaccine Policy Affects Health Equity? Evaluating Variability in the Advisory Committee on Immunization Practices' Equity AssessmentKathleen Dooling, Elif Alyanak, Dial Hewlett, et al.
BMC Infectious Diseases|February 19, 2025
Patient preferences for long-acting HIV treatment: a preference heterogeneity assessmentEnrique M Saldarriaga, Brett Hauber, Douglas Barthold, et al.
Journal of Patient Experience|November 29, 2023
Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug DevelopmentMaggie Jalowsky, Brett Hauber, Mariah Jacqueline Scott, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 15, 2015
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitusA Brett Hauber, Kaan Tunceli, Jui-Chen Yang, et al.
Patient Preference and Adherence|June 26, 2024
Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping ReviewBrett Hauber, Mark V Hand, Bruno C Hancock, et al.
Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Caution is needed for systematic reviews and interpretation of preference studiesJennifer A Whitty, Brett Hauber, Josh Coulter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 26, 2025
A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision MakingJonathan Mauer, Chiara Whichello, Brett Hauber, et al.
Pulmonary Therapy|October 28, 2024
Perspectives on Drug Product Design Among Patients with Lung Cancer in the United KingdomJoshua R Coulter, Louis Edward Baig, Amy Antipas, et al.
The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.
Pageof 17